Skip to content

Clinical trials

Phase 3 Migraine Disorders trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 3 Country / region: Spain Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20152
20164
20171
20181
20192
20206
20216
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting4
Terminated3
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Teva Branded Pharmaceutical Products R&D, Inc.5
H. Lundbeck A/S4
Pfizer4
AbbVie2
Novartis Pharmaceuticals2
Alder Biopharmaceuticals, Inc.1
Amgen1
Janssen Pharmaceutica N.V., Belgium1
Teva Branded Pharmaceutical Products R&D LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders26
Headache7
Nausea4
Photophobia4
Hyperacusis3
Recurrence2
Epilepsy1
Headache Disorders1
Headache Disorders, Secondary1
Vomiting1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.